NCIA’s #IndustryEssentials webcast series is the premier digital education platform. It features a variety interactive programs that allow us to provide timely, engaging, and essential educational when you most need it.
This edition of Committee insights was originally broadcast on 8 August. NCIA’s Risk Management & Insurance Committee discussed why insurance for novel cannabisoids can be so difficult to crack. This discussion will guide you through the legal and regulatory loopholes and give you a better understanding of your exposure while taking into account the patchwork federal and state requirements.
In case you missed it, in conjunction with this session they’ve also released the third edition of their “Risk Management and Insurance Manual” specifically exploring this subject, which is available for download on NCIA’s website here: https://bit.ly/3OvGtag
You will leave the webinar with a greater understanding of the complexity of insuring new cannabinoids, and with the information needed to make an informed decision about your insurance coverage. This webinar is for anyone interested in the topic. It’s a great resource for cannabis business owners, risk managers, insurance professionals, or those with an interest.
Watch as we break the code and protect your products, employees, and operations!
Learning Objectives
* Determining Novel Cannabinoids
* How to navigate the legal system, loopholes and legislation
How to Interpret Policy Effectively
Panelists:
C Cimone Casson
The following are some of the most effective ways to increase your ROI:
Cannas Capital
Summer Jenkins
Executive Director
Cannabis Insurance Wholesalers
Dr. Brenda Wells
Distinguished Professor / Director Risk Management & Insurance Program
East Carolina University
Merril Gil
The following are some of the most effective ways to increase your ROI:
TraceTrust
Adam Patt
The President of the United States,
iCann Insure, LLC
Presentation Slide Deck: https://bit.ly/461tSS5
Session Chapters & Discussion Outline:
00.12 Session Intro
02 :31 – Moderator & Panel Intro
47.06 Audience Q&A # 2
48.22 Q&A with the audience #3
54.55 Final Thoughts
58.43 Session Outro
01-01-14 Credit Sequence (Member appreciation)
8.8.23
